Development of an enzyme-linked immunoassay for the quantitation of influenza haemagglutinin: An alternative method to single radial immunodiffusion

Influenza and other Respiratory Viruses

Volumn 7, Issue 2, 2013, Pages 191-200

  Bodle, Jesse ^a   Verity, Erin E ^a   Ong, Chi ^a   Vandenberg, Kirsten ^a   Shaw, Robert ^b   Barr, Ian G ^b   Rockman, Steven ^a  

^a CSL LIMITED   (Australia)

^b WHO COLLABORATING CENTRE FOR REFERENCE AND RESEARCH ON INFLUENZA   (Australia)

Author keywords

Enzyme linked immunoassay; Haemagglutinin; Influenza vaccine; Single radial immunodiffusion; Vaccine stability

Indexed keywords

HORSERADISH PEROXIDASE; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ;

2009 H1N1 INFLUENZA; ARTICLE; CROSS REACTION; DRUG STABILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNODIFFUSION; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N1; NONHUMAN; PRIORITY JOURNAL; VALIDITY; VIRUS STRAIN;

ANTIBODIES, MONOCLONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HORSERADISH PEROXIDASE; HUMANS; IMMUNODIFFUSION; INFLUENZA VACCINES; TECHNOLOGY, PHARMACEUTICAL;

EID: 84873736985     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/j.1750-2659.2012.00375.x     Document Type: Article

References (26)

1. WHO. Influenza (seasonal) fact sheet. 2009. Available at: http://www.who.int/mediacentre/factsheets/fs211/en/index.html (Accessed 12th November 2009).
2. Wiley DC, Wilson IA, Skehel JJ. Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 1981; 29:289.
3. Knossow M, Gaudier M, Douglas A et al. Mechanism of neutralization of influenza virus infectivity by antibodies. Virology 2002; 302:294-298.
4. The Department of Health GB. British Pharmacopoeia: Crown Copyright. 2003.
5. Wood JM, Schild GC, Newman RW, Seagroatt V. Application of an improved single-radial-immunodiffusion technique for the assay of haemagglutinin antigen content of whole virus and subunit influenza vaccines. Dev Biol Stand 1977; 39:193-200.
6. He Q, Velumani S, Du Q et al. Detection of H5 avian influenza viruses by antigen-capture enzyme-linked immunosorbent assay using H5-specific monoclonal antibody. Clin Vaccine Immunol 2007; 14:617-623.
7. Kapteyn JC, Saidi MD, Dijkstra R et al. Haemagglutinin quantification and identification of influenza A&B strains propagated in PER.C6 cells: a novel RP-HPLC method. Vaccine 2006; 24:3137-3144.
8. Mayner RE, Blackburn RJ, Barry DW. Quantitation of influenza vaccine hemagglutinin by immunoelectrophoresis. Dev Biol Stand 1977; 39:169-178.
9. van de Donk HJ, de Jong JC, van Olderen MF, Osterhaus AD. Monoclonal antibodies for the control of influenza virusvaccines. Dev Biol Stand 1984; 57:251-255.
10. Williams TL, Luna L, Guo Z et al. Quantification of influenza virus hemagglutinins in complex mixtures using isotope dilution tandem mass spectrometry. Vaccine 2008; 26:2510-2520.
11. Pietrzykowski E, Margetts MB, MacFarlan RI, Webb EA, Cox JC, Edwards SJ. Antibody responses to HPV6b E polyproteins and production of monoclonal antibodies. Hybrid Hybridomics 2002; 21:333-338.
12. Dowdele W, Kendal A, Noble G. Influenza viruses; in Lenette E, Schmidt N (eds): Diagnostic Procedure for Viral, Rickettsial and Chlamydial Infections, 5 edn. Washington, DC: American Public Health Association, 1979; 585-609.
13. Bhatti A, Siddiqui YM, Micusan VV. Highly sensitive fluorogenic enzyme-linked immunosorbant assay: detection of staphylococcal enterotoxin B1. J Microbiol Methods 1994; 19:179-187.
14. Williams MS, Mayner RE, Daniel NJ et al. New developments in the measurement of the hemagglutinin content of influenza virus vaccines by single-radial-immunodiffusion. J Biol Stand 1980; 8:289-296.
15. Brownlee K. Statistical Theory and Methodology in Science and Engineering. New York: John Wiley and Sons, 1965.
16. Sokal RR, Rohlf FJ (eds). Biometry: The Principles and Practice of Statistics in Biological Research. New York: Freeman, 1994.
17. ICH Harmonised Tripartite Guidlines: Validation of Analytical Procedures: Text and Methodology Q2(R1). Available at: http://www.ich.org/products/guidelines/quality/article/quality-guidelines.html (Accessed 1 February 2010).
18. British Pharmacopoeia 2009. Influenza Vaccine (Split Virion Inactivated). Incorporating the Requirements of the European Pharmacopoeia 2002. Publisher: TSO (the stationary Office), Norwich, Norfolk, UK: Crown Copyright, 2009; 3166-3169.
19. Schild GC, Wood JM, Newman RW. A single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen. Proposals for an assay method for the haemagglutinin content of influenza vaccines. Bull World Health Organ 1975; 52:223-231.
20. Weis W, Brown JH, Cusack S, Paulson JC, Skehel JJ, Wiley DC. Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid. Nature 1988; 333:426-431.
21. Wei CJ, Xu L, Kong WP et al. Comparative efficacy of neutralizing antibodies elicited by recombinant hemagglutinin proteins from avian H5N1 influenza virus. J Virol 2008; 82:6200-6208.
22. Quan FS, Li ZN, Kim MC et al. Immunogenicity of low-pH treated whole viral influenza vaccine. Virology 2011; 417:196-202.
23. Quan FS, Huang C, Compans RW, Kang SM. Virus-like particle vaccine induces protective immunity against homologous and hetrologous strains of influenza virus. J Virol 2007; 81:3514-3524.
24. Epand RM, Epand RF. Thermal denaturation of influenza virus and its relationship to membrane fusion. Biochem J 2002; 365:841-848.
25. Vodeiko GM, Weir JP. Determination of H5N1 vaccine potecy using reference antisera from hetrologous strains of influenza. Influenza Other Respir Viruses 2011; 6, 176-187.
26. Rockman S, Schoofs P, Greenburg M. Development and testing of the Australian pandemic influenza vaccine - a timely response. Microbiol Aust 2011; 32:10-14.